Suboptimal adherence to repeat testing recommendations for men and women with positive chlamydia tests in the United States, 2008-2010

Clinical Infectious Diseases

Volumn 56, Issue 1, 2013, Pages 51-57

  Hoover, Karen W ^a   Tao, Guoyu ^a   Nye, Melinda B ^b   Body, Barbara A ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

chlamydia; positivity; retesting; testing

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; CHLAMYDIA; CHLAMYDIA TESTING; CHLAMYDIASIS; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PREDICTIVE VALUE; PREGNANT WOMAN; PRIORITY JOURNAL; REPEAT PROCEDURE; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TEST OF CURE; UNITED STATES;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CHLAMYDIA INFECTIONS; COHORT STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; UNITED STATES;

EID: 84871253979     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis771     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2010. Atlanta, GA: US Department of Health and Human Services, 2011.
2. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53:537-43.
3. Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005; 32:351-7.
4. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59(RR-12):1-110.
5. American College of Obstetricians and Gynecologists. Guidelines for women's health care, a resource manual. Third ed. Washington, DC: American College of Obstetricians and Gynecologists, 2007.
6. Screening for chlamydial infection: US Preventive Services Task Force recommendation statement. Ann Intern Med 2007; 147:128-34.
7. Perinatal infections. Guidelines for Perinatal Care. Sixth ed. Washington, DC: American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 2008:334-5.
8. Centers for Disease Control and Prevention. Male chlamydia screening consultation. Atlanta, Georgia, March 28-29, 2006. Available at: http://www.cdc.gov/std/chlamydia/ChlamydiaScreening-males.pdf. Accessed 9 August 2012.
9. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:651-81.
10. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003; 52(RR-12):1-24.
11. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58:362-5.
12. Hoover K, Tao G. Missed opportunities for chlamydia screening of young women in the United States. Obstet Gynecol 2008; 111: 1097-102.
13. Hoover K, Tao G, Kent C. Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics. Obstet Gynecol 2008; 112:891-8.
14. Hoover KW, Butler M, Workowski K, et al. STD screening of HIVinfected MSM in HIV clinics. Sex Transm Dis 2010; 37:771-6.
15. Mimiaga MJ, Helms DJ, Reisner SL, et al. Gonococcal, chlamydia, and syphilis infection positivity among MSM attending a large primary care clinic, Boston, 2003 to 2004. Sex Transm Dis 2009; 36:507-11.
16. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009; 36:478-89.
17. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001; 28:117-23.
18. Kjaer HO, Dimcevski G, Hoff G, Olesen F, Ostergaard L. Recurrence of urogenital Chlamydia trachomatis infection evaluated by mailed samples obtained at home: 24 weeks' prospective follow up study. Sex Transm Infect 2000; 76:169-72.
19. Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010; 201: 42-51.
20. Bakken IJ, Skjeldestad FE, Lydersen S, Nordbo SA. Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 2007; 34:739-43.
21. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 1997; 176(1 pt 1):103-7.
22. Kimani J, Maclean IW, Bwayo JJ, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996; 173:1437-44.
23. Satterwhite CL, Grier L, Patzer R, Weinstock H, Howards PP, Kleinbaum D. Chlamydia positivity trends among women attending family planning clinics: United States, 2004-2008. Sex Transm Dis 2011; 38:989-94.
24. Satterwhite CL, Tian LH, Braxton J, Weinstock H. Chlamydia prevalence among women and men entering the National Job Training Program: United States, 2003-2007. Sex Transm Dis 2010; 37:63-7.
25. Stephens SC, Snell A, Liska S, Rauch L, Philip SS, Bernstein KT. Disentangling screening and diagnostic chlamydia test positivity among females tested at title X-funded and adolescent health clinics, San Francisco 2009. Sex Transm Dis 2011; 38:630-3.
26. US Census Bureau. Current Population Survey (CPS) table creator 2012. Available at: http://www.census.gov/hhes/www/cpstc/cps-table-creator.html. Accessed 9 August 2012.
27. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998; 177:417-24.
28. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Longterm eradication of Chlamydia trachomatis genital infection after antimicrobial therapy: evidence against persistent infection. JAMA 1993; 270:2071-5.
29. Howard H. "The power of the pop-up": How one simple clinic systems-level intervention increased overall chlamydia/gonorrhea retesting rates. In: 2012 National STD Prevention Conference. Minneapolis, MN, 2012.
30. Burstein GR. Increasing chlamydia and gonorrhea retesting rates in a student health center using a quality improvement approach. In: 2012 National STD Prevention Conference. Minneapolis, MN, 2012.
31. Tao G, Hoover KW, Leichliter JS, Peterman TA, Kent CK. Self-reported chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008. Sex Transm Dis 2012; 39:605-7.
32. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006; 31:52-61.
33. Tao G, Hoover KW, Kent CK. Chlamydia testing patterns for commercially insured women, 2008. Am J Prev Med 2012; 42:337-41.
34. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW, 3rd. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35:119-23.